💊 BioNTech plans a blockbuster 2023; Measuring the carbon footprint of digital Tx

#211 | Lab-grown blood flows into veins

Hello, and welcome back to The Kable, where all the big news is from COP27. The world is watching to see if past promises materialise into current commitments for a fitter future.

For the third time in three years, Novartis is pumping in megabucks to boost manufacturing at Sandoz's antibiotics plant in Kundl, Austria. This time around, the Swiss firer of many is investing €50 million to up capacity for finished dose form penicillins by adding a new building at its manufacturing site.

Over in Poland, the former Prime Minister and leader of the ruling party says the country's birthrate is low because women are drinking alcohol. He expounded further by saying it takes men 20 years of excessive drinking to become alcoholic, while women achieve that status in just two years. We're beginning to understand why Jaroslaw Kaczyński is single even after 73 years.

In what feels like deja vu, India's Aurobindo Pharma and its US unit AuroMedics have issued product recalls for a blood pressure drug and an anticoagulant.

And finally, in good news for Malawi, the WHO has organised 2.9 million doses of the cholera vaccine for the country where the outbreak has been spreading relentlessly since March this year.